Literature DB >> 25738252

The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss.

Nicolas Kozakowski1, Harald Herkner2, Georg A Böhmig3, Heinz Regele1, Christoph Kornauth1, Gregor Bond3, Željko Kikić3.   

Abstract

By the Banff classification, the score of peritubular capillaritis, its extent, and its cellular composition should normally be reported in renal allograft pathology. While the score represents an important diagnostic and prognostic variable, the clinical value of capillaritis extent or composition has yet to be resolved. In a retrospective study of 749 renal transplant recipients subjected to 1322 indication biopsies, we found that prevalence scores of 1, 2, or 3 in the biopsy specimens were 10.7, 11.6, and 2.6%, respectively. Focal and diffuse peritubular capillaritis (inflammation over 50% of cortical peritubular capillaries) was diagnosed in 10.5 or 14.4% of cases, respectively. Mononuclear, granulocytic, and mixed peritubular capillaritis was present in 13.1, 3.3, and 8.5%, respectively. While peritubular capillaritis without further subclassification was not related to higher allograft loss rates, a score of 3 (hazard ratio 2.57 (CI: 1.25-5.28)) and diffuse peritubular capillaritis (1.67 (1.1-2.54)) were significant impartial risk factors for allograft loss. Diffuse peritubular capillaritis was independently associated with features of chronic antibody-mediated rejection and greater eGFR decline after 3 years. In contrast, detailed report of leukocytic composition in peritubular capillaritis did not confer additional prognostic information. Thus, in contrast to typing the infiltrating inflammatory cells, the score and extent of peritubular capillaritis in kidney allograft pathology is essential to assess transplant prognosis.

Entities:  

Mesh:

Year:  2015        PMID: 25738252     DOI: 10.1038/ki.2015.64

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection.

Authors:  H Regele; M Exner; B Watschinger; C Wenter; M Wahrmann; C Osterreicher; M D Säemann; N Mersich; W H Hörl; G J Zlabinger; G A Böhmig
Journal:  Nephrol Dial Transplant       Date:  2001-10       Impact factor: 5.992

2.  Banff 2003 meeting report: new diagnostic insights and standards.

Authors:  Lorraine C Racusen; Philip F Halloran; Kim Solez
Journal:  Am J Transplant       Date:  2004-10       Impact factor: 8.086

3.  A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.

Authors:  B Sis; G S Jhangri; J Riopel; J Chang; D G de Freitas; L Hidalgo; M Mengel; A Matas; P F Halloran
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

4.  Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema.

Authors:  K Trpkov; P Campbell; F Pazderka; S Cockfield; K Solez; P F Halloran
Journal:  Transplantation       Date:  1996-06-15       Impact factor: 4.939

5.  Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies.

Authors:  A Loupy; C Suberbielle-Boissel; G S Hill; C Lefaucheur; D Anglicheau; J Zuber; F Martinez; E Thervet; A Méjean; D Charron; J P Duong van Huyen; P Bruneval; C Legendre; D Nochy
Journal:  Am J Transplant       Date:  2009-09-22       Impact factor: 8.086

6.  Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

Authors:  Lorraine C Racusen; Robert B Colvin; Kim Solez; Michael J Mihatsch; Philip F Halloran; Patricia M Campbell; Michael J Cecka; Jean-Pierre Cosyns; Anthony J Demetris; Michael C Fishbein; Agnes Fogo; Peter Furness; Ian W Gibson; Denis Glotz; Pekka Hayry; Lawrence Hunsickern; Michael Kashgarian; Ronald Kerman; Alex J Magil; Robert Montgomery; Kunio Morozumi; Volker Nickeleit; Parmjeet Randhawa; Heinz Regele; Daniel Seron; Surya Seshan; Stale Sund; Kiril Trpkov
Journal:  Am J Transplant       Date:  2003-06       Impact factor: 8.086

7.  Determinants of poor graft outcome in patients with antibody-mediated acute rejection.

Authors:  C Lefaucheur; D Nochy; G S Hill; C Suberbielle-Boissel; C Antoine; D Charron; D Glotz
Journal:  Am J Transplant       Date:  2007-04       Impact factor: 8.086

8.  Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year.

Authors:  Evelyne Lerut; Maarten Naesens; Dirk R Kuypers; Yves Vanrenterghem; Boudewijn Van Damme
Journal:  Transplantation       Date:  2007-06-15       Impact factor: 4.939

9.  Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.

Authors:  Heinz Regele; Georg A Böhmig; Antje Habicht; Daniela Gollowitzer; Martin Schillinger; Susanne Rockenschaub; Bruno Watschinger; Dontscho Kerjaschki; Markus Exner
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

10.  Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Authors:  M Haas; B Sis; L C Racusen; K Solez; D Glotz; R B Colvin; M C R Castro; D S R David; E David-Neto; S M Bagnasco; L C Cendales; L D Cornell; A J Demetris; C B Drachenberg; C F Farver; A B Farris; I W Gibson; E Kraus; H Liapis; A Loupy; V Nickeleit; P Randhawa; E R Rodriguez; D Rush; R N Smith; C D Tan; W D Wallace; M Mengel
Journal:  Am J Transplant       Date:  2014-02       Impact factor: 8.086

View more
  8 in total

1.  Peritubular capillaritis in the renal allograft takes center stage.

Authors:  Lorraine C Racusen; Serena M Bagnasco
Journal:  Kidney Int       Date:  2015-08       Impact factor: 10.612

Review 2.  Current pathological perspectives on chronic rejection in renal allografts.

Authors:  Shigeo Hara
Journal:  Clin Exp Nephrol       Date:  2016-11-16       Impact factor: 2.801

3.  Chromatin Conformation Links Distal Target Genes to CKD Loci.

Authors:  Maarten M Brandt; Claartje A Meddens; Laura Louzao-Martinez; Noortje A M van den Dungen; Nico R Lansu; Edward E S Nieuwenhuis; Dirk J Duncker; Marianne C Verhaar; Jaap A Joles; Michal Mokry; Caroline Cheng
Journal:  J Am Soc Nephrol       Date:  2017-11-01       Impact factor: 10.121

Review 4.  Transplant glomerulopathy.

Authors:  Edward J Filippone; Peter A McCue; John L Farber
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

5.  The FCGR3A 158 V/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection.

Authors:  Nicolle Litjens; Annemiek Peeters; Judith Kal-van Gestel; Mariska Klepper; Michiel Betjes
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

6.  Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival.

Authors:  Markus Wahrmann; Bernd Döhler; Marie-Luise Arnold; Sabine Scherer; Katharina A Mayer; Susanne Haindl; Helmuth Haslacher; Georg A Böhmig; Caner Süsal
Journal:  Front Immunol       Date:  2021-08-23       Impact factor: 7.561

7.  The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection.

Authors:  Alexandre Loupy; Mark Haas; Candice Roufosse; Maarten Naesens; Benjamin Adam; Marjan Afrouzian; Enver Akalin; Nada Alachkar; Serena Bagnasco; Jan U Becker; Lynn D Cornell; Marian C Clahsen-van Groningen; Anthony J Demetris; Duska Dragun; Jean-Paul Duong van Huyen; Alton B Farris; Agnes B Fogo; Ian W Gibson; Denis Glotz; Juliette Gueguen; Zeljko Kikic; Nicolas Kozakowski; Edward Kraus; Carmen Lefaucheur; Helen Liapis; Roslyn B Mannon; Robert A Montgomery; Brian J Nankivell; Volker Nickeleit; Peter Nickerson; Marion Rabant; Lorraine Racusen; Parmjeet Randhawa; Blaise Robin; Ivy A Rosales; Ruth Sapir-Pichhadze; Carrie A Schinstock; Daniel Seron; Harsharan K Singh; Rex N Smith; Mark D Stegall; Adriana Zeevi; Kim Solez; Robert B Colvin; Michael Mengel
Journal:  Am J Transplant       Date:  2020-05-28       Impact factor: 8.086

8.  Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept.

Authors:  Mira Choi; Friederike Bachmann; Kaiyin Wu; Nils Lachmann; Danilo Schmidt; Susanne Brakemeier; Michael Duerr; Andreas Kahl; Kai-Uwe Eckardt; Klemens Budde; Peter Nickel
Journal:  BMC Nephrol       Date:  2020-08-20       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.